Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
Treatment of pediatric-onset multiple sclerosis (POMS) has been tailored after observational studies and data obtained from clinical trials in adult-onset multiple sclerosis (AOMS) patients. There are an increasing number of new therapeutic agents for AOMS, and many will be formally studied for use...
Main Authors: | Monica Margoni, Francesca Rinaldi, Paola Perini, Paolo Gallo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.676095/full |
Similar Items
-
Relapse Rate in Pediatric-Onset Multiple Sclerosis
by: J Gordon Millichap
Published: (2009-02-01) -
The Outcome of COVID-19 in Pediatric-Onset Multiple Sclerosis Patients
by: Alici, N., et al.
Published: (2022) -
Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
by: Hamdy SM, et al.
Published: (2018-02-01) -
MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis
by: Martin Weygandt, et al.
Published: (2015-01-01) -
Irinotecan in the treatment of colorectal cancer. A literature review
by: V. A. Ivanov, et al.
Published: (2017-04-01)